The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1, open-label, dose-escalation and expansion study of ABBV-399, an antibody drug conjugate (ADC) targeting c-Met, in patients (pts) with advanced solid tumors.
 
John H. Strickler
Consulting or Advisory Role - Amgen; Bayer; Bayer/Onyx; Boehringer Ingelheim; Celgene; Genentech/Roche; Marval Biosciences; Onyx
Research Funding - Abbvie (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Exelixis (Inst); Gilead Sciences (Inst); MedImmune (Inst); MethylGene (Inst); OncoMed (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
John J. Nemunaitis
No Relationships to Disclose
 
Colin D. Weekes
Honoraria - Celgene; Merrimack
Consulting or Advisory Role - Celgene; Merrimack
Research Funding - Millennium
Other Relationship - Celgene; Genentech/Roche
 
Ramesh K. Ramanathan
Honoraria - Celgene; Cerulean Pharma; Lilly; Pharmacyclics; Taiho Pharmaceutical; Vaccinex
Consulting or Advisory Role - Celgene; Genentech; Lilly; Vaccinex
Research Funding - Abbvie; Bayer; Biomarin; Celgene; Genentech; Halozyme; Merck/Schering Plough; Merrimack; Sanofi; Tekmira; Vaccinex; Verastem
Travel, Accommodations, Expenses - Biomarin
Other Relationship - Celgene
 
Eric Angevin
No Relationships to Disclose
 
Daniel Morgensztern
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Heat Biologics
Speakers' Bureau - Boehringer Ingelheim; Genentech
 
Rebecca Suk Heist
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Abbvie; Celgene; Debiopharm Group; Exelixis; GlaxoSmithKline; Incyte; Millennium; Mirati Therapeutics; Novartis; Peregrine Pharmaceuticals; Roche; Sanofi
 
Todd Michael Bauer
No Relationships to Disclose
 
Patrick Kaminker
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Xiaolin Fan
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Sara Siggelkow
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Shekman Wong
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Edward B. Reilly
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Daniel E. Afar
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Louie Naumovski
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Karen Kelly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Synta
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Lilly; Roche; Synta